{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T14:34:44Z","timestamp":1764599684021,"version":"3.46.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.acuroe.2025.501862","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:14:31Z","timestamp":1759342471000},"page":"501862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The unit volume biopsy length in prostate biopsy: Does it matter?"],"prefix":"10.1016","volume":"49","author":[{"given":"J.","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuroe.2025.501862_bib0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"year":"2025","series-title":"Cancer Statistics Review - SEER Statistics","key":"10.1016\/j.acuroe.2025.501862_bib0010"},{"issue":"3","key":"10.1016\/j.acuroe.2025.501862_bib0015","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0022-5347(01)61785-3","article-title":"Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng\/ml or less","volume":"161","author":"Carvalhal","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2025.501862_bib0020","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12916-021-02230-y","article-title":"Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients","volume":"20","author":"Merriel","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.acuroe.2025.501862_bib0025","article-title":"Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer","volume":"4","author":"Drost","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.acuroe.2025.501862_bib0030","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.euo.2022.04.006","article-title":"Diagnostic performance of prostate-specific membrane antigen positron emission tomography-targeted biopsy for detection of clinically significant prostate cancer: a systematic review and meta-analysis","volume":"5","author":"Kawada","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.acuroe.2025.501862_bib0035","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","article-title":"Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study","volume":"20","author":"Rouvi\u00e8re","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.acuroe.2025.501862_bib0040","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.eururo.2018.11.023","volume":"75","author":"van der Leest","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2025.501862_bib0045","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0022-5347(05)00957-2","article-title":"Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review","volume":"175","author":"Eichler","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2025.501862_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2020.03.020","article-title":"Systematic review and meta-analysis comparing cognitive vs. image-guided fusion prostate biopsy for the detection of prostate cancer","volume":"38","author":"Watts","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.acuroe.2025.501862_bib0055","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.eururo.2018.11.040","article-title":"The FUTURE Trial: a multicenter randomized controlled trial on target biopsy techniques based on magnetic resonance imaging in the diagnosis of prostate cancer in patients with prior negative biopsies","volume":"75","author":"Wegelin","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2025.501862_bib0060","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.eururo.2016.07.041","article-title":"Comparing three different techniques for magnetic resonance imaging-targeted prostate biopsies: a systematic review of in-bore versus magnetic resonance imaging-transrectal ultrasound fusion versus cognitive registration. Is there a preferred technique?","volume":"71","author":"Wegelin","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2025.501862_bib0065","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acuroe.2025.501862_bib0070","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jamaoncol.2020.7589","article-title":"Comparison of multiparametric magnetic resonance imaging-targeted biopsy with systematic transrectal ultrasonography biopsy for biopsy-naive men at risk for prostate cancer: a phase 3 randomized clinical trial","volume":"7","author":"Klotz","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.acuroe.2025.501862_bib0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.eururo.2004.04.006","article-title":"Handling and pathology reporting of prostate biopsies","volume":"46","author":"Boccon-Gibod","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2025.501862_bib0080","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1136\/jcp.56.5.336","article-title":"Guidelines for processing and reporting of prostatic needle biopsies","volume":"56","author":"van der Kwast","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.acuroe.2025.501862_bib0085","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00428-013-1466-5","article-title":"Guidelines on processing and reporting of prostate biopsies: the 2013 update of the pathology committee of the European Randomized Study of Screening for Prostate Cancer (ERSPC)","volume":"463","author":"van der Kwast","year":"2013","journal-title":"Virchows Arch"},{"key":"10.1016\/j.acuroe.2025.501862_bib0090","first-page":"659","article-title":"Systematic development of clinical practice guidelines for prostate biopsies: a 3-year Italian project","volume":"27","author":"Bertaccini","year":"2007","journal-title":"Anticancer Res"},{"key":"10.1016\/j.acuroe.2025.501862_bib0095","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.eururo.2005.07.011","article-title":"What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer?","volume":"48","author":"Descazeaud","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2025.501862_bib0100","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5301\/uro.5000199","article-title":"The impact of core length on prostate cancer diagnosis during a standard 14-core prostate biopsy scheme","volume":"83","author":"Dell\u2019Atti","year":"2016","journal-title":"Urologia"},{"key":"10.1016\/j.acuroe.2025.501862_bib0105","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.juro.2012.01.075","article-title":"Core length in prostate biopsy: size matters","volume":"187","author":"\u00d6bek","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2025.501862_bib0110","first-page":"6848","article-title":"Length of prostate biopsy cores: does it impact cancer detection?","volume":"20","author":"Fiset","year":"2013","journal-title":"Can J Urol"},{"key":"10.1016\/j.acuroe.2025.501862_bib0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12894-024-01596-4","article-title":"Importance of biopsy sample length for cancer diagnosis during trans-perineal prostate biopsy","volume":"24","author":"Zhu","year":"2024","journal-title":"BMC Urol"},{"key":"10.1016\/j.acuroe.2025.501862_bib0120","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.1016\/j.clgc.2016.02.011","article-title":"Does core length taken per cc of prostate volume in prostate biopsy affect the diagnosis of prostate cancer?","volume":"14","author":"Deliktas","year":"2016","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.acuroe.2025.501862_bib0125","article-title":"Clinical value of core length in contemporary multicore prostate biopsy","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.acuroe.2025.501862_bib0130","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00345-015-1536-1","article-title":"Minimum 6 mm core length is strongly predictive for the presence of glandular tissue in transrectal prostate biopsy","volume":"33","author":"Yilmaz","year":"2015","journal-title":"World J Urol"},{"key":"10.1016\/j.acuroe.2025.501862_bib0135","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00345-014-1371-9","article-title":"Gleason underestimation is predicted by prostate biopsy core length","volume":"33","author":"Reis","year":"2015","journal-title":"World J Urol"},{"key":"10.1016\/j.acuroe.2025.501862_bib0140","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.eururo.2005.12.057","article-title":"Needle core length is a quality indicator of systematic transperineal prostate biopsy","volume":"50","author":"Ficarra","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2025.501862_bib0145","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0090-4295(02)01515-7","article-title":"Needle core length in sextant biopsy influences prostate cancer detection rate","volume":"59","author":"Iczkowski","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.acuroe.2025.501862_bib0150","doi-asserted-by":"crossref","first-page":"E293","DOI":"10.5489\/cuaj.1248","article-title":"How reliable is 12-core prostate biopsy procedure in the detection of prostate cancer?","volume":"7","author":"Serefoglu","year":"2013","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.acuroe.2025.501862_bib0155","doi-asserted-by":"crossref","DOI":"10.1038\/srep16089","article-title":"Comparison between ultrasound guided transperineal and transrectal prostate biopsy: a prospective, randomized, and controlled trial","volume":"5","author":"Guo","year":"2015","journal-title":"Sci Rep"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578625001866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578625001866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T14:31:23Z","timestamp":1764599483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173578625001866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2173578625001866"],"URL":"https:\/\/doi.org\/10.1016\/j.acuroe.2025.501862","relation":{},"ISSN":["2173-5786"],"issn-type":[{"type":"print","value":"2173-5786"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The unit volume biopsy length in prostate biopsy: Does it matter?","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuroe.2025.501862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2025.501862","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"501862"}}